Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506898 | PMC |
| http://dx.doi.org/10.3109/09638288.2014.1002580 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ovarian reserve markers in women of reproductive ages with epilepsy.
Epilepsy Behav
September 2025
The Epilepsy Clinic, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Objective: The objective of this study was to examine ovarian reserve parameters in women with epilepsy compared to women without epilepsy.
Methods: A total of 80 women with epilepsy (WWE) from the epilepsy clinic at Rigshospitalet, Denmark, participated and completed the study between 2018-2022. A historical cohort collected from 2008 to 2010 of 418 women without epilepsy and no prior diagnosis of infertility was used as control.
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial.
Eur J Cancer
August 2025
Department of Surgery, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands; Cancer Center, Amsterdam, the Netherlands.
Introduction: This study aimed to assess whether total tumor volume (TTV) outperforms RECIST1.1 for treatment response assessment in patients with colorectal liver metastases (CRLM), and to investigate TTV as a predictive biomarker for the optimal systemic treatment regimen for individual patients with initially unresectable CRLM.
Methods: Patients with initially unresectable liver-only CRLM from the phase 3 CAIRO5 trial (NCT02162563) were included.
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.
Liver Int
October 2025
Gastroenterology, Hepatology and Transplantation Division, ASST Papa Giovanni XXIII, Bergamo, Italy.
Background And Aims: Hepatitis B (HBV) and Hepatitis Delta virus (HDV) infection have undergone significant changes in Italy over the past few decades, but reliable and updated prevalence of chronic hepatitis B (CHB) and Delta (CHD) data are lacking. The aim of the study was to describe the epidemiology of CHB and CHD in Italy in 2024, based on real-world data.
Methods: The number of patients with a healthcare expenditure exemption for CHB (016.
Hamstrings Volumetric Adaptations to a Four-Week Nordic Hamstring Exercise Protocol in Individuals with ACL Reconstruction: A Preliminary Case Series.
Int J Sports Phys Ther
September 2025
Background: Hamstrings atrophy is widely reported following anterior cruciate ligament reconstruction (ACLR) with hamstrings tendon (HT) autograft. Nordic hamstring exercise (NHE) has yielded improvements in hamstrings volumes among uninjured individuals, yet this has not been investigated following ACLR.
Purpose: To describe changes in hamstrings volumes following an isolated NHE protocol among individuals with a history of ACLR via HT.
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
July 2025
Université Paris Cité, Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Hemato-oncologie, Inserm U1153, Paris, France.
Background: In the absence of a head-to-head trial of off-the-shelf subcutaneous epcoritamab, a novel CD3xCD20 bispecific antibody, versus chimeric antigen receptor T-cell therapy (CAR T), a matching-adjusted indirect comparison (MAIC) of epcoritamab versus axicabtagene ciloleucel (axi-cel) efficacy was conducted in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) with ≥ 2 prior lines of systemic therapy.
Methods: The MAIC used epcoritamab patient-level data from EPCORE NHL-1 (NCT03625037; April 2023 data cutoff) and axi-cel aggregated data from ZUMA-1 (NCT02348216). Patients without prior CAR T were matched to the ZUMA-1 population; weighted regression models were used to estimate absolute differences in overall response rate (ORR) and complete response (CR) rate, and weighted Cox proportional-hazards models were used to estimate hazard ratios (HRs) for progression-free survival (PFS) and overall survival (OS).